Movie
Controller
Structure viewers
About EMN Papers
+Search query
-Structure paper
| Title | Systemic cancer therapy with engineered adenovirus that evades innate immunity. |
|---|---|
| Journal, issue, pages | Sci Transl Med, Vol. 12, Issue 571, Year 2020 |
| Publish date | Nov 25, 2020 |
 Authors | Svetlana Atasheva / Corey C Emerson / Jia Yao / Cedrick Young / Phoebe L Stewart / Dmitry M Shayakhmetov /  |
| PubMed Abstract | Oncolytic virus therapy is a cancer treatment modality that has the potential to improve outcomes for patients with currently incurable malignancies. Although intravascular delivery of therapeutic ...Oncolytic virus therapy is a cancer treatment modality that has the potential to improve outcomes for patients with currently incurable malignancies. Although intravascular delivery of therapeutic viruses provides access to disseminated tumors, this delivery route exposes the virus to opsonizing and inactivating factors in the blood, which limit the effective therapeutic virus dose and contribute to activation of systemic toxicities. When human species C adenovirus HAdv-C5 is delivered intravenously, natural immunoglobulin M (IgM) antibodies and coagulation factor X rapidly opsonize HAdv-C5, leading to virus sequestration in tissue macrophages and promoting infection of liver cells, triggering hepatotoxicity. Here, we showed that natural IgM antibody binds to the hypervariable region 1 (HVR1) of the main HAdv-C5 capsid protein hexon. Using compound targeted mutagenesis of hexon HVR1 loop and other functional sites that mediate virus-host interactions, we engineered and obtained a high-resolution cryo-electron microscopy structure of an adenovirus vector, Ad5-3M, which resisted inactivation by blood factors, avoided sequestration in liver macrophages, and failed to trigger hepatotoxicity after intravenous delivery. Systemic delivery of Ad5-3M to mice with localized or disseminated lung cancer led to viral replication in tumor cells, suppression of tumor growth, and prolonged survival. Thus, compound targeted mutagenesis of functional sites in the virus capsid represents a generalizable approach to tailor virus interactions with the humoral and cellular arms of the immune system, enabling generation of "designer" viruses with improved therapeutic properties. |
 External links | Sci Transl Med / PubMed:33239388 / PubMed Central |
| Methods | EM (single particle) |
| Resolution | 3.8 Å |
| Structure data |  EMDB-21049: |
